The Microbiome of Kidney Stones and Urine of Patients with Nephrolithiasis

Overview

Journal Urolithiasis

Publisher Springer

Specialty Urology

Date 2023 Jan 3

PMID 36596939

Authors

Ursula Lemberger

Petra Pjevac

Bela Hausmann

David Berry

Daniel Moser

Victoria Jahrreis

Mehmet Ozsoy

Shahrokh F Shariat

Julian Veser

Affiliations

Soon will be listed here.

Abstract

The incidence of nephrolithiasis is rising worldwide. Although it is a multifactorial disease, lifestyle plays a major role in its etiology. Another considerable factor could be an aberrant microbiome. In our observational single-center study, we aimed to investigate the composition of bacteria in kidney stones and urine focusing on patients with features of metabolic syndrome. Catheterized urine and kidney stones were collected prospectively from 100 consecutive patients undergoing endoscopic nephrolithotomy between 2020 and 2021 at our clinic. Microbiome composition was analyzed via 16S rRNA gene amplicon sequencing. Detection of bacteria was successful in 24% of the analyzed kidney stones. These patients had a prolonged length of stay compared to patients without verifiable bacteria in their stones (2.9 vs 1.5 days). Patients with features of metabolic syndrome were characterized by kidney stones colonized with classical gastrointestinal bacteria and displayed a significant enrichment of Enterococcaceae and Enterobacteriaceae. Stones of patients without features of metabolic syndrome characterized by Ureaplasma and Staphylococcaceae. Patients with bacteria in their kidney stones exhibit a longer length of stay, possibly due to more complex care. Patients presenting with features of metabolic syndrome displayed a distinct stone microbiome compared to metabolically fit patients. Understanding the role of bacteria in stone formation could enable targeted therapy, prevention of post-operative complications and new therapeutic strategies.

Citing Articles

Dietary index for gut microbiota and its protective role against kidney stones: evidence of diabetes as a mediator from NHANES cross-sectional data.

Wang L, Wu J, Jiang Z, Wang C, Lin F, Zhong Y Front Nutr. 2025; 12:1532313.

PMID: 40008311 PMC: 11852834. DOI: 10.3389/fnut.2025.1532313.

Lifestyle Factors and the Microbiome in Urolithiasis: A Narrative Review.

Koudonas A, Tsiakaras S, Tzikoulis V, Papaioannou M, de la Rosette J, Anastasiadis A Nutrients. 2025; 17(3).

PMID: 39940323 PMC: 11820711. DOI: 10.3390/nu17030465.

Gut Microbiota Comparison in Rectal Swabs Versus Stool Samples in Cats with Kidney Stones.

Joubran P, Roux F, Serino M, Deschamps J Microorganisms. 2025; 12(12.

PMID: 39770613 PMC: 11677927. DOI: 10.3390/microorganisms12122411.

Current Trends and Technological Advancements in the Use of Oxalate-Degrading Bacteria as Starters in Fermented Foods-A Review.

Al-Kabe S, Niamah A Life (Basel). 2024; 14(10).

PMID: 39459637 PMC: 11509417. DOI: 10.3390/life14101338.

Effect of flexible cystoscopy combined with flexible ureteroscopy on short-term outcomes in patients with complex renal stones.

He H, Zhang J, He W, Liu A, Liu L Am J Transl Res. 2024; 16(9):4515-4525.

PMID: 39398599 PMC: 11470314. DOI: 10.62347/NZGO3556.

References

Barr-Beare E, Saxena V, Hilt E, Thomas-White K, Schober M, Li B . The Interaction between Enterobacteriaceae and Calcium Oxalate Deposits. PLoS One. 2015; 10(10):e0139575. PMC: 4598009. DOI: 10.1371/journal.pone.0139575. View

Callahan B, Sankaran K, Fukuyama J, McMurdie P, Holmes S . Bioconductor Workflow for Microbiome Data Analysis: from raw reads to community analyses. F1000Res. 2016; 5:1492. PMC: 4955027. DOI: 10.12688/f1000research.8986.2. View

McMurdie P, Holmes S . phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data. PLoS One. 2013; 8(4):e61217. PMC: 3632530. DOI: 10.1371/journal.pone.0061217. View

Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

Pjevac P, Hausmann B, Schwarz J, Kohl G, Herbold C, Loy A . An Economical and Flexible Dual Barcoding, Two-Step PCR Approach for Highly Multiplexed Amplicon Sequencing. Front Microbiol. 2021; 12:669776. PMC: 8173057. DOI: 10.3389/fmicb.2021.669776. View

Zampini A, Nguyen A, Rose E, Monga M, Miller A . Defining Dysbiosis in Patients with Urolithiasis. Sci Rep. 2019; 9(1):5425. PMC: 6443657. DOI: 10.1038/s41598-019-41977-6. View

Huang R, Soneson C, Ernst F, Rue-Albrecht K, Yu G, Hicks S . TreeSummarizedExperiment: a S4 class for data with hierarchical structure. F1000Res. 2021; 9:1246. PMC: 7684683. DOI: 10.12688/f1000research.26669.2. View

Denburg M, Koepsell K, Lee J, Gerber J, Bittinger K, Tasian G . Perturbations of the Gut Microbiome and Metabolome in Children with Calcium Oxalate Kidney Stone Disease. J Am Soc Nephrol. 2020; 31(6):1358-1369. PMC: 7269359. DOI: 10.1681/ASN.2019101131. View

Chewcharat A, Curhan G . Trends in the prevalence of kidney stones in the United States from 2007 to 2016. Urolithiasis. 2020; 49(1):27-39. DOI: 10.1007/s00240-020-01210-w. View

10.

Pohl H, Groah S, Perez-Losada M, Ljungberg I, Sprague B, Chandal N . The Urine Microbiome of Healthy Men and Women Differs by Urine Collection Method. Int Neurourol J. 2020; 24(1):41-51. PMC: 7136448. DOI: 10.5213/inj.1938244.122. View

11.

Shoag J, Tasian G, Goldfarb D, Eisner B . The new epidemiology of nephrolithiasis. Adv Chronic Kidney Dis. 2015; 22(4):273-8. DOI: 10.1053/j.ackd.2015.04.004. View

12.

Scales Jr C, Curtis L, Norris R, Springhart W, Sur R, Schulman K . Changing gender prevalence of stone disease. J Urol. 2007; 177(3):979-82. DOI: 10.1016/j.juro.2006.10.069. View

13.

Flannigan R, Battison A, De S, Humphreys M, Bader M, Lellig E . Evaluating factors that dictate struvite stone composition: A multi-institutional clinical experience from the EDGE Research Consortium. Can Urol Assoc J. 2018; 12(4):131-136. PMC: 5905542. DOI: 10.5489/cuaj.4804. View

14.

Wagenius M, Borglin J, Popiolek M, Forsvall A, Stranne J, Linder A . Percutaneous nephrolithotomy and modern aspects of complications and antibiotic treatment. Scand J Urol. 2020; 54(2):162-170. DOI: 10.1080/21681805.2020.1740316. View

15.

Magruder M, Sholi A, Gong C, Zhang L, Edusei E, Huang J . Gut uropathogen abundance is a risk factor for development of bacteriuria and urinary tract infection. Nat Commun. 2019; 10(1):5521. PMC: 6893017. DOI: 10.1038/s41467-019-13467-w. View

16.

Callahan B, McMurdie P, Rosen M, Han A, Johnson A, Holmes S . DADA2: High-resolution sample inference from Illumina amplicon data. Nat Methods. 2016; 13(7):581-3. PMC: 4927377. DOI: 10.1038/nmeth.3869. View

17.

Lippert K, Kedenko L, Antonielli L, Kedenko I, Gemeier C, Leitner M . Gut microbiota dysbiosis associated with glucose metabolism disorders and the metabolic syndrome in older adults. Benef Microbes. 2017; 8(4):545-556. DOI: 10.3920/BM2016.0184. View

18.

Kachroo N, Lange D, Penniston K, Stern J, Tasian G, Bajic P . Standardization of microbiome studies for urolithiasis: an international consensus agreement. Nat Rev Urol. 2021; 18(5):303-311. PMC: 8105166. DOI: 10.1038/s41585-021-00450-8. View

19.

Romero V, Akpinar H, Assimos D . Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol. 2010; 12(2-3):e86-96. PMC: 2931286. View

20.

Turk C, Petrik A, Sarica K, Seitz C, Skolarikos A, Straub M . EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol. 2015; 69(3):475-82. DOI: 10.1016/j.eururo.2015.07.041. View